Close Menu
Aspire Market Guides
  • Home
  • Alternative Investments
  • Cryptocurrency
  • Economics
  • Equity Investments
  • Mutual Funds
  • Real Estate
  • Trading
What's Hot

The Rise of Stablecoins in B2B

September 27, 2026

Is Clorox (CLX) Trading Below Fair Value On Earnings?

September 27, 2026

BlackRock Investor News: If You Have Suffered Losses in

September 27, 2026
Facebook X (Twitter) Instagram
Trending:
  • The Rise of Stablecoins in B2B
  • Is Clorox (CLX) Trading Below Fair Value On Earnings?
  • BlackRock Investor News: If You Have Suffered Losses in
  • US, China buy time with trade truce as pressure builds
  • Paralympic silver medalist dies after road accident in Okinawa
  • Finance, Market Barriers Slow Ethiopia’s Circular Economy Push
  • Michael Saylor Proposes a Digital Rights Framework for the AI and Bitcoin Era
  • Russian Forces Strike Port and Civilian Infrastructure in Kiliia | Ukraine news
  • High Prices and Rising Debt: Can $5,000 Dividend Checks Sway Voters?
  • Concrete Bricks Market Forecast to 2035: Urban Infrastructure Demand Drives Steady Growth – News and Statistics
Sunday, September 27
Facebook X (Twitter) Instagram
Aspire Market Guides
  • Home
  • Alternative Investments
  • Cryptocurrency
  • Economics
  • Equity Investments
  • Mutual Funds
  • Real Estate
  • Trading
Aspire Market Guides
Home»Trading»Is Clorox (CLX) Trading Below Fair Value On Earnings?
Trading

Is Clorox (CLX) Trading Below Fair Value On Earnings?

By CharlotteSeptember 27, 20264 Mins Read
Share
Facebook Twitter Pinterest Email Copy Link


Clorox has seen its share price slide over recent years, which naturally pushes investors to ask whether the current US$83.80 level is still aligned with what the business earns. With the focus squarely on earnings power rather than headlines, the question is how well the stock price and the profit stream match up today.

  • Over the past 5 years, the share price has fallen 39.3%, which puts the spotlight on whether the earnings profile can still support the current valuation.
  • The business relies on branded household products that tend to generate steady revenue and cash flow, which can support an earnings based valuation even when sentiment around the stock is weak.
  • There is a second opinion on Clorox worth weighing. See what analysts think Clorox’s shares could be worth.

The issue now is whether Clorox’s present share price is justified by its earnings when set against a Fair Ratio benchmark.

To compare how fairly Clorox is being priced on its earnings against other opportunities, you can run the same test across a wider list of 32 high quality undervalued stocks

Is Clorox Still Cheap on Earnings?

The P/E ratio fits Clorox because investors usually judge mature, branded consumer businesses on the cash they can earn per share. On this yardstick, Clorox trades on about 17.3x earnings, which is lower than both the Household Products industry average of roughly 16.1x and the broader peer group around 19.6x, so the stock does not screen as aggressively priced on headline earnings.

A more tailored benchmark is the Fair Ratio, which reflects what P/E you might expect given Clorox’s size, margins and risk profile. The present 17.3x multiple sits below that Fair Ratio, which points to the shares changing hands at a discount to what this framework suggests could be justified by the business fundamentals. Explore the numbers behind Clorox’s P/E valuation.

NYSE:CLX P/E Ratio as at Sep 2026
NYSE:CLX P/E Ratio as at Sep 2026

The Clorox Narrative: What Would Justify Today’s Price?

Simply Wall St Narratives for Clorox pick up where the valuation puzzle leaves off and spell out what combination of future growth, margins and earnings would need to play out for the stock to be worth materially more or less than today’s price. Instead of a single ratio or model output, they map the business assumptions sitting underneath that number so you can track over time whether Clorox’s actual progress keeps matching the story implied by the valuation.

Clorox currently attracts two very different readings, with one side focused on an earnings rebuild and the other on rising execution and category risks.

Bull case: 17% undervalued

“Expansion of health and hygiene as Clorox’s main focus, including the GOJO and Clorox Healthcare platforms that now represent over half of company sales…”

Discover why this Narrative puts Clorox at 17% undervalued.

Bear case: 9% overvalued

“Intensifying consumer shift toward sustainable and zero-waste lifestyles, along with growing skepticism about chemical-based cleaning products, threatens to erode Clorox’s core category revenues…”

Explore why this Narrative puts Clorox at 9% overvalued.

Before acting on Clorox’s valuation, there is one more piece to examine

The people setting Clorox’s priorities, and how their paychecks line up with long term owners, can tilt the whole investment case. That alignment puzzle has not been unpacked here yet. See who runs Clorox and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



Source link

Related Posts

Trading

Bitcoin (BTC) Price Prediction: BTC Holds Uptrend as $84K FVG Shapes Intraday Setup

September 26, 2026
Trading

Medpace Holdings (MEDP) On Choppy Trading Is Its Premium Quality Story Already Priced In

September 26, 2026
Trading

South Korea tightens scalping rules as gray areas persist for spots and lines – CHOSUNBIZ – Chosunbiz

September 26, 2026
Trading

Review: When scalping was a lucrative business

September 25, 2026
Trading

Canada’s firm response to US trade pressure could boost its position, Washington draws growing pushback: expert

September 25, 2026
Trading

FundedFast Appoints Author and Trading Analyst Gabriele Nigro

September 25, 2026
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

The Rise of Stablecoins in B2B

September 27, 2026

Is Clorox (CLX) Trading Below Fair Value On Earnings?

September 27, 2026

BlackRock Investor News: If You Have Suffered Losses in

September 27, 2026

US, China buy time with trade truce as pressure builds

September 27, 2026
SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.


I consent to being contacted via telephone and/or email and I consent to my data being stored in accordance with European GDPR regulations and agree to the terms of use and privacy policy.

Featured

Early SpaceX investor Atreides hires co-CIO of Lone Pine – Financial Times

September 13, 2026

First Lady Melania Raked In $17M From Books, NFTs and a Film

July 1, 2026

Securities firms reap windfall from foreign high-frequency traders; possible cause for market volatility

September 9, 2026
Monthly Featured

130 Darlington homes approved for Burtree Garden Village

May 6, 2026

Why RingCentral (RNG) Stock Is Trading Up Today

July 25, 2026

Gold prices rise again across Pakistan

April 27, 2026
Latest Posts

The Rise of Stablecoins in B2B

September 27, 2026

Is Clorox (CLX) Trading Below Fair Value On Earnings?

September 27, 2026

BlackRock Investor News: If You Have Suffered Losses in

September 27, 2026
SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.


I consent to being contacted via telephone and/or email and I consent to my data being stored in accordance with European GDPR regulations and agree to the terms of use and privacy policy.

© 2026 Aspire Market Guides.
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Type above and press Enter to search. Press Esc to cancel.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first.

Complete the form below to subscribe to our weekly newsletter.


I consent to being contacted via telephone and/or email and I consent to my data being stored in accordance with European GDPR regulations and agree to the terms of use and privacy policy.